Inari Medical Inc. is a high-risk healthcare company based in the United States that specializes in developing medical devices to treat Chronic Venous Disease. Their product portfolio, including ClotTriever and FlowTriever System, focus on helping patients with deep vein thrombosis and pulmonary embolism. With a Risk Rating Score of 30.6, Inari Medical Inc. is committed to providing ESG-focused solutions for patient care. The company primarily generates revenue in the United States with a presence in international markets as well.